The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Gordeeva M.V.

Sankt-Peterburgskiĭ gosudarstvennyĭ universitet

Mitrofanova L.B.

Almazov National Medical Research Center, Saint-Petersburg, Russia

Grokhotova V.V.

FGBU "Federal'nyĭ tsentr serdtsa, krovi i éndokrinologii im. V.A. Almazova"

Arrhythmogenic right ventricular cardiomyopathy/dysplasia as a cause of sudden cardiac death

Authors:

Gordeeva M.V., Mitrofanova L.B., Grokhotova V.V.

More about the authors

Read: 1982 times


To cite this article:

Gordeeva MV, Mitrofanova LB, Grokhotova VV. Arrhythmogenic right ventricular cardiomyopathy/dysplasia as a cause of sudden cardiac death. Russian Journal of Archive of Pathology. 2013;75(6):51‑55. (In Russ.)

Recommended articles:

References:

  1. Elliot P., Andersson B., Arbustini E. et al. Classification of the cardiomyopathies: a position statement from the European society of cardiology working group on myocardial and pericardial diseases. Eur. Heart J. 2008; 29 (2): 270-6.
  2. Basso C., Corrado D., Bauce B., Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Circ. Arrhythm. Electrophysiol. 2012; 5 (6): 1233-46.
  3. Corrado D., Basso C., Thiene G. Arrhythmogenic right ventricular cardiomyopathy: an update. Heart. 2009; 95 (9): 766-73.
  4. Virmani R., Burke A.R., Farb A. Pathologic experience in USA. In: Nava A., Rossi L., Thiene G., eds. Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Amsterdam: Elsevier; 1997: 87-93.
  5. Thiene G., Nava A., Corrado D. et al. Right ventricular cardiomyopathy and sudden death in young people. N. Engl. J. Med. 1988; 318: 129-33.
  6. Corrado D., Thiene G., Nava A. et al. Exercize-related sudden death in the young. Eur. Heart J. 1993; 86: 368A.
  7. Cox M.G.P.J., van der Smagt J.J., Noorman M. et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy diagnostic task force criteria. Impact of New Task Force Criteria. Circ. Arrhythm. Electrophysiol. 2010; 3: 126-33.
  8. Corrado D., Basso C., Schiavon M. et al. Screening for hypertrophic cardiomyopathy in young athletes. N. Engl. J. Med. 1998; 339: 364-9.
  9. Bowles N.E., Ni J., Marcus F. et al. The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Am. Coll. Cardiol. 2002; 39: 892-5.
  10. Ananthasubramaniam K., Khaja F. Arrhythmogenic right ventricular dysplasia/ cardiomyopathy: review for the clinician. Prog. Cardiovasc. Dis. 1998; 41: 237-46.
  11. Kaplan S.R., Gard J.J., Carvajal-Huerta L. et al. Structural and molecular pathology of the heart in Carvajal syndrome. Cardiovasc. Pathol. 2004; 13: 26-32.
  12. Kapplinger J., Landstrom A., Salisbury B. et al. Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. J. Am. Coll. Cardiol. 2011; 57 (23): 2317-27.
  13. Fast V.G., Kléber A.G. Role of wavefront curvature in propagation of cardiac impulse. Cardiovasc. Res. 1997; 33: 258-71.
  14. Lombardi R., Marian A. Molecular genetics and pathogenesis of arrhythmogenic tight ventricular cardiomyopathy: a disease of cardiac stem cells. Pediatr. Cardiol. 2011; 32: 360-5.
  15. Nattel S., Schott J.J. Arrhythmogenic right ventricular dysplasia type 1 and mutations in transforming growth factor Β3 gene regulatory regions: a breakthrough? Cardiovasc. Res. 2005; 65: 302-4.
  16. Grumbach I.M., Heim A., Vonhof S. et al. Coxsackievirus genome in myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Cardiology. 1998; 89: 241-5.
  17. Golukhova E.Z. Aritmogennaya displaziya/kardiopatiya pravogo zheludochka. Annaly aritmologii. 2008; 3: 5-24.
  18. Mitrofanova L.B., Beshchuk O.V., Tatarskii R.B., Lebedev D.S. Aritmogennaya kardiomiopatiya pravogo zheludochka i virusnaya infektsiya: vozmozhnye sochetaniya i rol' v geneze zheludochkovykh takhiaritmii. Vestnik aritmologii. 2009; 58: 15-9.
  19. Mallat Z., Tedjui A., Fontaliran F. et al. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N. Engl. J. Med. 1996; 335: 1190-6.
  20. Valente M., Calabrese F., Thiene G. et al. In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. Am. J. Pathol. 1998; 152: 479-84.
  21. D'Amati G., Di Gioia C., Giordano C., Gallo P. Myocyte transdifferentiation: a possible pathogenetic mechanism for arrhythmogenic right ventricular cardiomyopathy. Arch. Pathol. Lab. Med. 2000; 124 (2): 287-90.
  22. Asimaki A., Saffitz J. The role of endomyocardial biopsy in ARVC: looking beyond histology in search of new diagnostic markers. Cardiovasc. Electrophysiol. 2011; 22 (1): 111-7.
  23. McKenna W.J., Thiene G., Nava A. et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy: Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br. Heart J. 1994; 71: 215-8.
  24. Marcus F.I., McKenna W.J., Sherrill D. et al. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/ Dysplasia. Proposed Modification of the Task Force Criteria. Circulation. 2010; 121: 1533-41.
  25. Corrado D., Basso C., Thiene G. et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J. Am. Coll. Cardiol. 1997; 30: 1512-20.
  26. Sen-Chowdhry S., Syrris P., Prasad S.K. et al. Leftdominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J. Am. Coll. Cardiol. 2008; 52: 2175-87.
  27. Mitrofanova L.B., Beshchuk O.V., Naumova E.Yu. Diagnostika aritmogennoi displazii pravogo zheludochka po endomiokardial'noi biopsii i rol' virusov v patogeneze zabolevaniya. Arkhiv patologii. 2011; 73 (5): 27-30.
  28. Corrado D., Basso C., Nava A. et al. Sudden death in young people with apparently isolated mitral valve prolapse. G. Ital. Cardiol. 1998; 5: 600-2.
  29. Obayashi K., Miyagawa-Tomita S., Matsumoto H. et al. Effects of transforming growth factor-Β3 and matrix metalloproteinase-3 on the pathogenesis of chronic mitral valvular disease in dogs. Am. J. Vet. Res. 2011; 72 (2): 194-202.
  30. Basso C., Thiene G. Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy. Just a matter of fat? Cardiovasc. Pathol. 2005; 14: 37-41.
  31. Billman G.E., Lappi M.D. Effects of cocaine on cardiac vagal tone before and during coronary artery occlusion: cocaine exacerbates the autonomic response to myocardial ischemia. J. Cardiovasc. Pharmacol. 1993; 22: 869-76.
  32. Peng S.K., French W.J., Pelikan P.C. Direct cocaine cardiotoxicity demonstrated by endomyocardial biopsy. Arch. Pathol. Lab. Med. 1989; 113: 842-5.
  33. Kakturskii L.V., Rybakova M.G., Kuznetsova I.A. Vnezapnaya serdechnaya smert' (morfologicheskaya diagnostika). Biblioteka patologoanatoma. vyp. 100. SPb.; 2008. 79 s.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.